Literature DB >> 26835072

Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants.

Pepie Tsolka1.   

Abstract

This review discusses the basic pharmacology of new oral anticoagulants that are used for prevention of thromboembolism in patients with atrial fibrillation. It presents available evidence, and provides recommendations for the management of patients requiring invasive procedures in dental practice.

Entities:  

Keywords:  New oral anticoagulants; atrial fibrillation; dental procedures

Year:  2014        PMID： 26835072      PMCID： PMC4711592          DOI： 10.15420/aer.2014.3.2.85

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  41 in total

Review 1.  Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants.

Authors:  Denise E van Diermen; Isaäc van der Waal; Johan Hoogstraten
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-10-11

2.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

3.  Periprocedural bridging management of anticoagulation.

Authors:  Waldemar E Wysokinski; Robert D McBane
Journal:  Circulation       Date:  2012-07-24       Impact factor: 29.690

Review 4.  Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.

Authors:  Joanne van Ryn; Joachim Stangier; Sebastian Haertter; Karl-Heinz Liesenfeld; Wolfgang Wienen; Martin Feuring; Andreas Clemens
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

5.  Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

Authors:  Pierre Sié; Charles M Samama; Anne Godier; Nadia Rosencher; Annick Steib; Juan V Llau; Philippe Van der Linden; Gilles Pernod; Thomas Lecompte; Isabelle Gouin-Thibault; Pierre Albaladejo
Journal:  Arch Cardiovasc Dis       Date:  2011-10-29       Impact factor: 2.340

Review 6.  Acute management of bleeding in patients on novel oral anticoagulants.

Authors:  Deborah M Siegal; Mark A Crowther
Journal:  Eur Heart J       Date:  2012-12-07       Impact factor: 29.983

7.  Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

Authors:  Stefan Knecht; Christian Oelschläger; Thomas Duning; Hubertus Lohmann; Johannes Albers; Christoph Stehling; Walter Heindel; Günter Breithardt; Klaus Berger; E Bernd Ringelstein; Paulus Kirchhof; Heike Wersching
Journal:  Eur Heart J       Date:  2008-07-29       Impact factor: 29.983

Review 8.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

Review 9.  Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism.

Authors:  Pierre Fontana; Samuel Z Goldhaber; Henri Bounameaux
Journal:  Eur Heart J       Date:  2014-02-07       Impact factor: 29.983

10.  Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000.

Authors:  Masaki Ohsawa; Akira Okayama; Kiyomi Sakata; Karen Kato; Kazuyoshi Itai; Toshiyuki Onoda; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2005-09       Impact factor: 3.211
View more
  2 in total

Review 1.  Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

Authors:  Adrian Curto; Alberto Albaladejo; Alfonso Alvarado
Journal:  J Clin Exp Dent       Date:  2017-02-01

Review 2.  Managing patients taking edoxaban in dentistry.

Authors:  Adrian Curto; Daniel Curto; Jorge Sanchez
Journal:  J Clin Exp Dent       Date:  2017-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.